CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations.

about

CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations.

Item

http://www.wikidata.org/entity/Q38924458

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

CRE: a cost effective and rapi ...... etect EGFR and KRAS mutations.

@en

type

Item

label

CRE: a cost effective and rapi ...... etect EGFR and KRAS mutations.

@en

prefLabel

CRE: a cost effective and rapi ...... etect EGFR and KRAS mutations.

@en

P1476

CRE: a cost effective and rapi ...... detect EGFR and KRAS mutations

@en

P2093

Anuradha Choughule

http://www.w3.org/2001/XMLSchema#string

Kuldeep J Patel

http://www.w3.org/2001/XMLSchema#string

Kumar Prabhash

http://www.w3.org/2001/XMLSchema#string

Kunal Karve

http://www.w3.org/2001/XMLSchema#string

Mukul Godbole

http://www.w3.org/2001/XMLSchema#string

P2860

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcome

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Rapid assembly of multiple-exon cDNA directly from genomic DNA.

P304

160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12688/F1000RESEARCH.6663.2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Amit Dutt

Maulik Vyas

Manoj P Ramteke

P577

2015-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27127615

http://www.w3.org/2001/XMLSchema#string

P932

4830212

http://www.w3.org/2001/XMLSchema#string